drugset / Trial / NCT06685835
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.
Timeline
- Start
- 2024-12-16
- Primary completion
- 2026-02-12
- Completion
- 2026-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brensocatib | Small molecule | 10 mg | Oral |
| Subject | Brensocatib | Small molecule | 40 mg | Oral |